• Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
  • New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
  • Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
  • Researchers Provide New Insights into Melanoma Immune Resistance
  • New Clinical Trial Underway for Treatment of Advanced Melanoma
  • Skin Cancer Awareness Month Brings Sun Safety to Schools
  • First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
  • ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
  • Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
  • Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
  • Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
  • IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group